2022 – 至今 主任委员，中国疫苗协会疫苗经济学专业委员会
2019 – 至今 副主任委员、秘书长，中国卫生经济学会公共卫生经济专业委员会
2021 - 2024 公共卫生管理体制研究，中国国家社科基金重大专项，主持（首席专家）
2023 - 2026 基于真实世界的水痘疫苗有效性、安全性及卫生经济学评价研究，北京市自然科学基金重点项目，主持
2021 - 2024 新冠疫苗接种的卫生经济学评价研究，国家重点研发计划，任务主持
2022 - 2024 卫生系统视角的初级卫生保健在慢性病管理中的作用机制研究，北京市自然科学基金面上项目，主持
2019 - 2020 第一届中国国家自然科学基金与比尔及梅琳达盖茨基金会全球健康联合研讨会，中国国家自然科学基金/比尔及梅琳达盖茨基金会，主持
2019 - 2020 An Economic Evaluation of Haemophius Influenzae Type b (Hib) Vaccine for the introduction of China’s National Immunization Program (NIP), 比尔及梅琳达盖茨基金会，主持
2018 - 2021 基于医生代理理论的中国家庭医生签约服务和效果研究，中国国家自然科学基金面上项目，主持
2018 - 2019 A subsidy program of gestational diabetes mellitus screening and lifestyle treatment in rural China，美国中华医学基金会 (China Medical Board)，主持
2015 - 2018 Learning from health systems strengthening in maternal and newborn health (MNH) in China to inform accelerated progress for saving，英国医学研究会 (Medical Research Council)/伦敦卫生和热带学院，主持
2014 - 2017 医改背景下我国医疗保障制度对卫生不平等的作用机制和政策绩效研究，中国国家自然科学基金面上项目，主持
（#通讯作者或者共同通讯作者（责任作者）；*指导的研究生或博士后为第一作者或者共同第一作者)
1.Fang H#, Eggleston K, Hanson K, Wu M. Enhancing financial protection under China’s social health insurance to achieve universal health coverage. BMJ 2019;365:l2378.
2.Zhang H*, Lai X*, Patenaude BN, Jit M, Fang H#, Adding new childhood vaccines to China’s National Immunization Program: evidence, benefits, and priorities. Lancet Public Health 2023;8(12):e1016-e1024.
3.Lai X*, Zhang H*, Pouwels KB, Patenaude B, Jit M, Fang H#. Estimating global and regional between-country inequality in routine childhood vaccine coverage in 195 countries and territories from 2019 to 2021: a longitudinal study. EClinicalMedicine 2023;60:102042.
4.Lai X*, Yuan Y, Wang H, Zhang R, Qiao Q, Feng X, Jin A, Li H, Li J, Si L, Gao P, Jan S, Fang H#, Wu Y#; DECIDE-Salt Research Group. Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities: The DECIDE-Salt Cluster Randomized Clinical Trial. JAMA Network Open. 2024 Feb 5;7(2):e2355564.
5.Zhang H*, Patenaude B, Zhang H, Jit M, Fang H#. Global vaccine coverage and childhood survival estimates 1990-2019. Bulletin of World Health Organization 2024; BLT.23.290129. https://cdn.who.int/media/docs/default-source/bulletin/online-first/blt.23.290129.pdf?sfvrsn=8c6c239c_3
6.Feng H*, Zhang H, Ma C, Zhang H, Yin D#, Fang H#. National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis. Lancet Regional Health Western Pacific. 2023 March;32:100639.
7.Lai X*, Garcia C, Wu D, Knoll M, Zhang H, Xu T, Jing R, Ying Z#, Wahl B#, Fang H#. Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis. Lancet Regional Health Western Pacific. 2023 March;32:100666.
8.Zhang H*, Lai X, Mak J, Sriudomporn S, Zhang H, Fang H#, Patenaude B. Coverage and Equity of Childhood Vaccines in China. JAMA Network Open. 2022;5(12):e2246005.
9.Zhang H*, Garcia C, Yu W, Knoll M, Lai X, Xu Ting, Jing R, Qin Y, Yin Z#, Wahl B#, Fang H#. National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis. BMC Medicine. 2021 Aug 11;19(1):181.
10.Rong H*, Lai X, Jing R, Wang X, Fang H#, Mahmoudi E. Association of sensory impairments with cognitive decline and depression among older adults in China. JAMA Network Open. 2020;3(9):e2014186.
方海，主编《中国疫苗卫生经济学评价指南2022》，北京大学医学部-中国疾病预防控制中心疫苗经济学联合研究中心，2022
方海，主编《我国非免疫规划疫苗卫生经济学评价》，人民卫生出版社，2021
Fang H, Rizzo JA. Physician labor supply, in Encyclopedia of Health Economics, edited by Culyer A. Elsevier. 2014, pp.56-60.
